申请人:CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
公开号:US20220119376A1
公开(公告)日:2022-04-21
The present invention discloses a series of tricyclic compounds and use thereof in preparing a medicament for treating a disease related to CRBN protein. Specifically, the present invention discloses a derivative compound of formula (I) or a pharmaceutically acceptable salt thereof.